Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients

Bone Marrow Transplantation volume 30, pages 321–326 (2002)Cite this article

Abstract

We report three cases of post-transplant lymphoproliferative disorder (PTLD) in the context of autologous stem cell transplantation (ASCT) for multiple myeloma (MM) and non-Hodgkin's lymphoma. The first two cases received ASCT for MM, one with a CD34-selected autograft and the other with an unmanipulated autograft. Both these cases of PTLD achieved a complete response following treatment with IVIG, gancyclovir, solumedrol and interferon (IFN). The third case received ASCT with an unmanipulated autograft for relapsed angioimmunoblastic lymphoma. He also achieved a complete response but only after rituximab was added to IVIG, gancyclovir, solumedrol and IFN. None of these patients experienced a relapse of their PTLD with follow-up ranging from 1.5 to 5 years. These cases highlight the importance of considering PTLD in the differential diagnosis of lymphadenopathy and fever post ASCT. They also demonstrate the possibility of durable complete remission of post-ASCT PTLD following antiviral and immune modulating therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Boubenider S, Hiesse C, Goupy C et al. Incidences and consequences of post-transplantation lymphoproliferative disorders J Nephrol 1997 10: 136 145

    CAS  PubMed  Google Scholar 

  2. Swinnen LJ . Diagnosis and treatment of transplant-related lymphoma Ann Oncol 2000 11: (Suppl. 1) S45 S48

    Article  Google Scholar 

  3. Lones MA, Kirov I, Said JW et al. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient Bone Marrow Transplant 2000 26: 1021 1024

    Article  CAS  Google Scholar 

  4. Anderson KC, Soiffer R, DeLage R et al. T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications Blood 1990 76: 235 244

    CAS  Google Scholar 

  5. Shepard JD, Gascoyne RD, Barnett MJ et al. Polyclonal Epstein–Barr virus associated lymphoproliferative disorder following autografting for chronic myeloid leukemia Bone Marrow Transplant 1995 15: 639 641

    Google Scholar 

  6. Stewart DA, Guo D, Morris D et al. Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens Bone Marrow Transplant 1999 23: 111 117

    Article  CAS  Google Scholar 

  7. Nolte A, Buhmann, Straka C et al. Assessment and characterization of the cytolytic T lymphocyte response against Epstein–Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation Bone Marrow Transplant 1998 21: 909 916

    Article  CAS  Google Scholar 

  8. Briz M, Fores R, Regidor C et al. Epstein–Barr virus associated B-cell lymphoma after autologous bone marrow transplantation for T-cell acute lymphoblastic leukemia Br J Haematol 1997 98: 485 487

    Article  CAS  Google Scholar 

  9. Young L, Alfieri C, Hennessy K et al. Expression of Epstein–Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease New Engl J Med 1989 321: 1080 1085

    Article  CAS  Google Scholar 

  10. Chao NJ, Berry GJ, Advani R et al. Epstein–Barr virus associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma Transplantation 1993 55: 1425 1428

    Article  CAS  Google Scholar 

  11. Hauke RJ, Greiner TC, Smir BN et al. Epstein–Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases Bone Marrow Transplant 1998 21: 1271 1274

    Article  CAS  Google Scholar 

  12. Leblond V, Davi F, Charlotte F et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 1998 16: 2052 2059

    Article  CAS  Google Scholar 

  13. Sakai Y, Ohga S, Tonegawa Y et al. Interferon-alpha therapy for chronic active Epstein–Barr virus infection: potential effect on the development of T-lymphoproliferative disease J Pediatr Hematol Oncol 1998 20: 342 346

    Article  CAS  Google Scholar 

  14. Davis CL . The antiviral prophylaxis of post-transplant lymphoproliferative disorder Springer Semin Immunopathol 1998 20: 437 453

    Article  CAS  Google Scholar 

  15. Pirsch JD, Stratta RJ, Sollinger HW et al. Treatment of severe Epstein–Barr virus induced lymphoproliferative syndrome with gancyclovir: two cases after solid organ transplantation Am J Med 1989 86: 241 244

    Article  CAS  Google Scholar 

  16. Yufu Y, Kimura M, Kawano R et al. Epstein–Barr virus associated lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease Bone Marrow Transplant 2000 26: 1339 1341

    Article  CAS  Google Scholar 

  17. Faro A . Interferon-alpha and its effects on post-transplant lymphoproliferative disorders Springer Semin Immunopathol 1998 20: 425 436

    Article  CAS  Google Scholar 

  18. Shapiro RS, Chauvenet A, McGuire W et al. Treatment of B-cell lymphoproliferative disorders with interferon alpha and intravenous gamma globulin New Engl J Med 1988 318: 1334

    Article  CAS  Google Scholar 

  19. O'Brien S, Bernert RA, Logan JL, Lien YH . Remission of posttransplant lymphoproliferative disorder after interferon alpha treatment J Am Soc Nephrol 1997 8: 1483 1489

    CAS  PubMed  Google Scholar 

  20. Davis CL, Wood BL, Sabath DE et al. Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants Transplantation 1998 66: 1770 1779

    Article  CAS  Google Scholar 

  21. Kluin-Nelemans HC, Kester MG, van de Corput L et al. Correction of abnormal T-cell receptor repertoire during interferon-alpha therapy in patients with hairy cell leukemia Blood 1998 91: 4224 4231

    CAS  PubMed  Google Scholar 

  22. Fischer A, Blanche S, Le Bidois J et al. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation New Engl J Med 1991 324: 1451 1456

    Article  CAS  Google Scholar 

  23. Milpied N, Antoine C, Garnier JL et al. Humanized anti-CD 20 monoclonal antibody (rituximab) in B posttransplant lymphoproliferative disorders (B PTLDs): a retrospective analysis of 32 patients Ann Oncol 2000 11: (Suppl. 1) 113 116

    Article  Google Scholar 

  24. Kuehnle I, Huls MH, Semmelmann M et al. CD 20 monoclonal antibody (rituximab) for therapy of Epstein–Barr virus lymphoma after hemopoietic stem-cell transplantation Blood 2000 95: 1502 1505

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Calgary and Tom Baker Cancer Center, Calgary, Alberta, Canada

    D Jenkins, A Chaudhry, D Morris, S Glück, A Jones, R Woodman, CB Brown, J Russell & DA Stewart

  2. Department of Pathology, University of Calgary and Tom Baker Cancer Center, Calgary, Alberta, Canada

    L DiFrancesco

Authors
  1. D Jenkins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L DiFrancesco
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Chaudhry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Glück
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Woodman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. CB Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. DA Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jenkins, D., DiFrancesco, L., Chaudhry, A. et al. Successful treatment of post-transplant lymphoproliferative disorder in autologous blood stem cell transplant recipients. Bone Marrow Transplant 30, 321–326 (2002). https://doi.org/10.1038/sj.bmt.1703603

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703603

Keywords

This article is cited by

Search

Advanced search

Quick links